132 participants
Evaluate the Efficacy and Safety of Irochel for the Management of Iron Overload in Thalassemia Patients in Comparison With Deferoxamine
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-25
- Start Date:
- 2019-02-11
- Completion:
- 2020-01-30
Conditions
- Iron Overload Due to Repeated Red Blood Cell Transfusions
- Thalassemia Majors (Beta-Thalassemia Major)
Interventions
- DRUG
No Results Yet